title: Surrogate markers now provide physicians with the best means to manage antiretroviral therapy: the case for.
authors.affiliation: Kobler Clinic, Chelsea and Westminster Hospital, London.
authors.forename: G J
authors.initials: GJ
authors.lastname: Moyle
authors.forename: B G
authors.initials: BG
authors.lastname: Gazzard
authors.forename: T
authors.initials: T
authors.lastname: Peto
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015415:Biomarkers; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D011379:Prognosis; D012367:RNA, Viral / Q000097:blood; D012189:Retrospective Studies; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D015415:Biomarkers; D012367:RNA, Viral